C.F.R. homeSearch C.F.R.
C.F.R.Title 42Chapter I—Public Health Service, Department of Health and Human ServicesSubchapter H—Health Assessments and Health Effects Studies of Hazardous Substances Releases and FacilitiesPart 93—Public Health Service Policies on Research MisconductSubpart A—General

42 C.F.R. § 93.100 (2026)

General policy

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 2010–2023 10citing cases
At a glance

Courts have cited this section in 10 opinions since 2010, 2 of them in the last five years. The most litigated part is subsection (b) (2 cases).

(a) Research misconduct involving Public Health Service (PHS) support is contrary to the interests of the PHS and the Federal Government, to the health and safety of the public, to the integrity of research, and to the conservation of public funds.

(b) The U.S. Department of Health and Human Services (HHS) and institutions that apply for or receive PHS support for biomedical or behavioral research, biomedical or behavioral research training, or activities related to that research or research training share responsibility for the integrity of the research process. HHS has ultimate oversight authority for PHS-supported research, and for taking other actions as appropriate or necessary, including the right to assess allegations and to perform inquiries or investigations at any time. Institutions and institutional members have an affirmative duty to protect PHS funds from misuse by ensuring the integrity of all PHS-supported work, and primary responsibility for responding to and reporting allegations of research misconduct, as provided in this part.

The 10 cases that cite 42 C.F.R. § 93.100 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENKumar v. George Washington Univ., 174 F. Supp. 3d 172 (D.D.C. 2016).
cites § 93.100 4×cited by 17 cases
Where it cites § 93.100
“” 42 C.F.R. § 93.100 (b). HHS “has delegated responsibility for addressing research integrity and misconduct issues related to PHS supported activities” to ORI.”
Later courts cite it for
“could not be fairly characterized as the product of reasoned decision-making.” · 2 citing courts
2
GREENMauvis-Jarvis v. Wong, 2013 IL App (1st) 120070, 987 N.E.2d 864.
cites § 93.100 3×cited by 43 cases
Where it cites § 93.100
“” 42 C.F.R. § 93.100 (b) (2005) “Research misconduct” is defined as: “fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results.”
The case’s holding
Absolute privilege does not bar a defamation claim if the plaintiff sufficiently alleges that the defendant acted with malice or reckless disregard for the truth.
Later courts cite it for
“where absolute privilege is granted, no cause of action for defamation lies against the person making the statement even if it is made with malice.” · 3 citing courts
3
GREENCabi v. Boston Child.'s Hosp., 161 F. Supp. 3d 136 (D. Mass. 2016).
cites § 93.100 1×cited by 15 cases
Where it cites § 93.100
“Third, Plaintiffs note that BCH acted in a “quasi-judicial investigatory and disciplinary capacity for the federal government” pursuant to 42 C.F.R. § 93.100 et seq., D. 33 ¶ 241; D.”
4
GREENYuan v. Johns Hopkins Univ., 135 A.3d 519 (Md. Ct. Spec. App. 2016).
cites § 93.100 3×cited by 3 cases
Where it cites § 93.100
“Yuan based his wrongful discharge action on 42 C.F.R. § 93.100 et seq., which establishes a federal administrative mechanism to police intentional, knowing, or reckless “research misconduct” that represents “a significant departure from accepted practices of the relevant…”
5
GREENBrodie v. United States Dep't of Health & Human Servs., 715 F. Supp. 2d 74 (D.D.C. 2010).
cites § 93.100 2×cited by 7 cases
Where it cites § 93.100
“” 42 C.F.R. § 93.100 (b)(2009). HHS regulations provide that “[r]esearch misconduct involving PHS support is contrary to the interests of the PHS and the Federal government and to the health and safety of the public, to the integrity of research, and to the conservation of…”
6
NO FLAGC. Helm v. Allison Ratterman, No. 17-6367 (6th Cir. June 18, 2019).
cites § 93.100 1×subsections: (b)cited by 0 casesunpublished
Where it cites § 93.100
“42 C.F.R § 93.100(b) provides that “[i]nstitutions and institutional members have an affirmative duty to protect PHS funds from misuse by ensuring the integrity of all PHS supported work, and primary responsibility for responding to and reporting allegations of research…”
7
NO FLAGRae v. Child.'s Nat'l Med. Ctr., No. 2015-0736 (D.D.C. Dec. 28, 2020).
cites § 93.100 1×cited by 0 cases
Where it cites § 93.100
“1, et seq and 42 C.F.R. 93.100, et seq.), and four District of Columbia Code provisions pertaining generally to assaults and victim’s rights ( D.”
8
NO FLAGWilliam Helm v. Allison Ratterman, Phd, No. 2020 CA 001434 (Ky. Ct. App. Feb. 17, 2022).
cites § 93.100 1×cited by 0 casesunknown
Summary
No passage or summary on file for this case yet.
9
cites § 93.100 1×subsections: (b)cited by 0 cases
Where it cites § 93.100
“” 42 C.F.R. 93.100(b). Defendant states that as a partner institution with certain responsibilities under the federal scheme, OSU is required to comply with ORI’s rules governing research misconduct.”
10
NO FLAGBrodie v. United States Dep't of Health & Human Servs., No. 2010-0544 (D.D.C. June 4, 2010).
cites § 93.100 1×cited by 0 cases
Where it cites § 93.100
“” 42 C.F.R. § 93.100 (b) (2009). HHS regulations provide that “[r]esearch misconduct involving PHS support is contrary to the interests of the PHS and the Federal government and to the health and safety of the public, to the integrity of research, and to the conservation of…”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
201020162023

One bar per year. Tallest: 3 cases in 2016. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
D.D.C.46th Cir.1Ill. App. Ct.1Ky. Ct. App.1D. Mass.1Md. Ct. Spec. App.1Ohio Ct. Cl.1
By subsection
(b)2 cases
C. Helm v. Allison Ratterman, No. 17-6367 (6th Cir. June 18, 2019).“42 C.F.R § 93.100(b) provides that “[i]nstitutions and institutional members have an affirmative duty to protect PHS funds from misuse by ensuring the integrity of all PHS supported work, and primary responsibility for responding to and reporting allegations of research…”
Croce v. Ohio State Univ. Bd. of Trs., 2023-Ohio-2656.“” 42 C.F.R. 93.100(b). Defendant states that as a partner institution with certain responsibilities under the federal scheme, OSU is required to comply with ORI’s rules governing research misconduct.”
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com